Scope Infection Lawsuit Patients across the United States have filed medical scope infection lawsuits after contaminated endoscopes and duodenoscopes allegedly transmitted dangerous bacterial infections during procedures such as ERCP, colonoscopy, and other endoscopic treatments.
Spinal Cord Stimulator Lawsuit Spinal cord stimulator lawsuits allege that implanted pain devices malfunctioned, migrated, or caused nerve damage, often forcing patients to undergo revision or removal surgery.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Breast Mesh Lawsuit Lawyers are investigating breast mesh lawsuits for women who suffered infections, pain, or implant failure from internal bra implants used in breast reconstruction surgery.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Sports Betting Addiction Lawsuit Sports betting addiction lawsuits are being investigated for college students and young adults who developed gambling problems after using apps like FanDuel and DraftKings, alleging that the platforms failed to warn about the addictive nature of their features and marketing practices.
Dicamba Should Remain Banned Until Crop Drift Problem Solved, Environmental Groups’ Report States August 13, 2020 Irvin Jackson Add Your CommentsA new report calls for federal regulators to continue to blocking use of the herbicide dicamba, until a solution is found to problems where the weed killer drifts onto unprotected fields, causing widespread crop damage.The Prairie River News Network and the Xerces Society for Invertebrate Conservation released the report last week, โDrifting Toward Disasterโ, highlighting how dicamba-based herbicides has damaged more than 5 million acres of cultivated and wild landscapes; an area roughly the size of New Jersey.Dicamba is a synthetic herbicide that is sold under the brand names Xtendimax, Engenia, and Fexapan, which has been used for years by farmers nationwide to control weeds.Do You Know about…Spinal Cord Stimulator lawsuitsSpinal cord stimulator lawsuits are being investigated for individuals who suffered unnecessary shocks, burns or other problems, often resulting in the need for additional surgery to remove the SCS.Learn MoreSEE IF YOU QUALIFY FOR COMPENSATIONDo You Know AboutโฆSpinal Cord Stimulator lawsuitsSpinal cord stimulator lawsuits are being investigated for individuals who suffered unnecessary shocks, burns or other problems, often resulting in the need for additional surgery to remove the SCS.Learn MoreSEE IF YOU QUALIFY FOR COMPENSATIONWhile dicamba was traditionally only applied during certain times of the year, use of the herbicide increased dramatically after new seeds were introduced in 2016, which were genetically modified to be tolerant of the weedkiller. This was designed to allow farmers to use dicamba โover-the-topโ, as the crops were emerging from the ground. However, problems have been linked to dicamba driving onto neighboring farms, where it has caused wide-spread damage to crops of farmers who decided not to purchase the genetically modified seeds.In June, the U.S. Ninth Circuit Court of Appealsย vacated the U.S. Environmental Protection Agency (EPA) approval of dicamba formulationsย for the weed killers XtendiMax, FeXapan and Engenia, determining that the EPA did not pay enough attention to the risk of dicamba crop damage on neighboring farms.As a result of the ruling, the EPA issued a final cancellation order, which allowed limited distribution of existing stocks of the three weed killers by commercial applicators until July 31. That deadline has now passed.However, there is a chance the manufacturers could make some changes that placates the EPA and gets dicamba put back on the market, some say. This latest report calls on the EPA to make resolving the dicamba drift problem a priority in that scenario.โDespite this court ruling, along with a recent $400 million settlement that compensates farmers for dicambarelated crop damage, the manufacturers are pursuing new registrations for these products for the 2021 growing season,โ the report notes.The report makes a number of recommendations, calling for the EPA to require independent research to prove dicamba formulations will not cause off-target damage to crops. The report also calls for the EPA to conduct a full risk assessment for endangered animal and plant species; reject petitions for deregulation that could increase dicamba use; and to push for sustainable weed management that includes multiple approaches to managing weeds instead of relying solely on herbicides.Dicamba LawsuitsDozens of dicamba drift lawsuitsย have been filed since August 2017, alleging that Monsanto rushed a system to market that encouraged the increased use of dicamba, while withholding or concealing information from regulatory authorities about the volatility of dicamba-resistant crops.Farmers and environmental groups say the herbicide drifts onto neighboring crops that are not dicamba tolerant, killing them and forcing farmers to buy the genetically engineered seeds so their crops arenโt killed by dicamba.In February, a Missouri jury awardedย $265 millionย to a peach farmer in the first dicamba crop damage lawsuit to go to trial. The verdict included $15 million in compensatory damages and $250 million in punitive damages, designed to punish Monsanto and BASF for their reckless behavior in marketing the widespread use of the weed killer.The dicamba lawsuits claimed the high volatility is seen as a feature by the manufacturers, meant to force other farmers to use their expensive products to grow dicamba-tolerant GMO crops if they donโt want to suffer losses when their neighbors spray. Written by: Irvin JacksonSenior Legal Journalist & Contributing EditorIrvin Jackson is a senior investigative reporter at AboutLawsuits.com with more than 30 years of experience covering mass tort litigation, environmental policy, and consumer safety. He previously served as Associate Editor at Inside the EPA and contributes original reporting on product liability lawsuits, regulatory failures, and nationwide litigation trends. Tags: BASF, Bayer, Dicamba, Engenia, Fexapan, Genetically Modified Organisms, Herbicide, Monsanto, Soybeans, Weed Killer, XtendiMaxMore Lawsuit Stories Bard PowerPort Fracture Lawsuit Set For Second Bellwether Trial in Aug. 2026 May 29, 2026 Spinal Cord Stimulator Malpractice Lawsuit Claims Device Left Veteran Partially Paralyzed May 29, 2026 Top Fitness Lawsuit Claims Home Gym Machine Failed, Crushing Womanโs Legs May 29, 2026 0 Comments URLThis field is for validation purposes and should be left unchanged.Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes NoPost Comment I authorize the above comments be posted on this pageWeekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings.Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA TermΔ MORE TOP STORIES Bard PowerPort Fracture Lawsuit Set For Second Bellwether Trial in Aug. 2026 (Posted: yesterday)The second Bard PowerPort bellwether trial is now scheduled to begin in August after the plaintiff in a claim originally planned for trial next month died, and her family stopped pursuing litigation.MORE ABOUT: BARD POWERPORT LAWSUITJury Returns Defense Verdict in First Bard PowerPort Injury Lawsuit (05/11/2026)Jury Selection Underway in First Bard PowerPort Trial Over Infection Claims (04/16/2026)Judge Blocks Juries From Hearing About IVC Filter Problems in Bard PowerPort Trials (04/08/2026) Dupixent Cancer Lawsuit Claims Eczema Drug Caused Womanโs CTCL Diagnosis (Posted: 2 days ago)A Delaware woman has filed a Dupixent lawsuit, claiming manufacturers promoted the eczema drug as a breakthrough treatment while failing to warn that it may trigger or worsen CTCL, a rare form of non-Hodgkinโs lymphoma.MORE ABOUT: DUPIXENT LAWSUITLink Between Dupixent and Cancer Withheld From Doctors and Users, Lawsuit Alleges (05/11/2026)Lawsuit Indicates Dupixent Lymphoma Diagnosis Resulted in Multiple Rounds of Chemotherapy (05/01/2026)Judges Will Consider MDL for Dupixent Cancer Lawsuits Late Next Month (04/21/2026) Omnipod Recall Impacts Another 7 Million Defective Pods That May Cause DKA, Hospitalization (Posted: 3 days ago)Federal regulators have expanded an Omnipod recall after reports that internal tubing defects may cause insulin leaks and under-delivery, potentially triggering dangerous blood sugar spikes.MORE ABOUT: OMNIPOD RECALL LAWSUITRecalled Omnipod 5 Injuries Skyrocket, Prompting Removal of Insulin Pump Pods (04/30/2026)Insulet OmniPod 5 Recall Lawsuits May Be Filed Over Problems Resulting in Diabetic Ketoacidosis, Hospitalization and Death (03/24/2026)Omnipod 5 Insulin Pump Recall Follows Reports of Serious Injuries: FDA (03/20/2026)
Spinal Cord Stimulator Malpractice Lawsuit Claims Device Left Veteran Partially Paralyzed May 29, 2026
Bard PowerPort Fracture Lawsuit Set For Second Bellwether Trial in Aug. 2026 (Posted: yesterday)The second Bard PowerPort bellwether trial is now scheduled to begin in August after the plaintiff in a claim originally planned for trial next month died, and her family stopped pursuing litigation.MORE ABOUT: BARD POWERPORT LAWSUITJury Returns Defense Verdict in First Bard PowerPort Injury Lawsuit (05/11/2026)Jury Selection Underway in First Bard PowerPort Trial Over Infection Claims (04/16/2026)Judge Blocks Juries From Hearing About IVC Filter Problems in Bard PowerPort Trials (04/08/2026)
Dupixent Cancer Lawsuit Claims Eczema Drug Caused Womanโs CTCL Diagnosis (Posted: 2 days ago)A Delaware woman has filed a Dupixent lawsuit, claiming manufacturers promoted the eczema drug as a breakthrough treatment while failing to warn that it may trigger or worsen CTCL, a rare form of non-Hodgkinโs lymphoma.MORE ABOUT: DUPIXENT LAWSUITLink Between Dupixent and Cancer Withheld From Doctors and Users, Lawsuit Alleges (05/11/2026)Lawsuit Indicates Dupixent Lymphoma Diagnosis Resulted in Multiple Rounds of Chemotherapy (05/01/2026)Judges Will Consider MDL for Dupixent Cancer Lawsuits Late Next Month (04/21/2026)
Omnipod Recall Impacts Another 7 Million Defective Pods That May Cause DKA, Hospitalization (Posted: 3 days ago)Federal regulators have expanded an Omnipod recall after reports that internal tubing defects may cause insulin leaks and under-delivery, potentially triggering dangerous blood sugar spikes.MORE ABOUT: OMNIPOD RECALL LAWSUITRecalled Omnipod 5 Injuries Skyrocket, Prompting Removal of Insulin Pump Pods (04/30/2026)Insulet OmniPod 5 Recall Lawsuits May Be Filed Over Problems Resulting in Diabetic Ketoacidosis, Hospitalization and Death (03/24/2026)Omnipod 5 Insulin Pump Recall Follows Reports of Serious Injuries: FDA (03/20/2026)